Lactitol - PharmaKB

Lactitol

Pizensy (lactitol) is a small molecule pharmaceutical. Lactitol was first approved as Pizensy on 2020-02-12.

Download report

Favorite

FDA Novel Drug Approvals 2020

Events Timeline

Commercial

Clinical

Drug

Target

Variants

Financial

Trends

Safety

Events Timeline

YTD

Max

Events

FDA approval date

EMA approval date

Patent expiration date

Study first post date

Last update post date

Start date

Primary completion date

Completion date

Results first post date

Mock data
Subscribe for the real data

Commercial

Therapeutic Areas

No data

Trade Name

FDA

EMA

No data

Drug Products

FDA

EMA

New Drug Application (NDA)

Abbreviated New Drug Application (ANDA)

Lactitol

Tradename	Company	Number	Date	Products
PIZENSY	Braintree Laboratories	N-211281 DISCN	2020-02-12	1 products, RLD

Hide discontinued

Labels

FDA

EMA

No data

Indications

FDA

EMA

No data

Agency Specific

FDA

EMA

Expiration	Code
LACTITOL, PIZENSY, BRAINTREE LABS
2025-02-12	NCE

Patent Expiration

Patent	Expires	Flag	FDA Information
Lactitol, Pizensy, Braintree Labs
10806743	2037-05-12		U-1516

ATC Codes

A: Alimentary tract and metabolism drugs

— A06: Drugs for constipation

— A06A: Drugs for constipation

— A06AD: Osmotically acting laxatives

— A06AD12: Lactitol

HCPCS

No data

Clinical

Clinical Trials

429 clinical trials

View more details

Mock data
Subscribe for the real data

Indications Phases 4

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Meningococcal infections	D008589	EFO_0004249	A39	—	18	24	2	2	44
Meningitis	D008581	HP_0001287	G03	—	7	22	1	—	28
Malaria	D008288	EFO_0001068	B54	1	1	8	12	6	27
Human influenza	D007251	EFO_0007328	J11.1	3	9	6	2	3	23
Chronic obstructive pulmonary disease	D029424	EFO_0000341	J44.9	—	—	10	7	1	18
Obstructive lung diseases	D008173	HP_0006536	—	—	—	9	5	—	14
Neoplasms	D009369	—	C80	3	7	1	4	—	13
Falciparum malaria	D016778	EFO_0007444	B50	1	1	3	6	2	12
Syndrome	D013577	—	—	2	4	2	2	3	11
Breast neoplasms	D001943	EFO_0003869	C50	1	2	3	2	3	11

Show 94 more

Indications Phases 3

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Healthy volunteers/patients	—	—	—	42	1	1	—	6	50
Meningococcal meningitis	D008585	EFO_1001040	A39.0	—	7	19	—	—	24
Influenza in birds	D005585	—	J09.X	2	2	1	—	—	5
Osteoarthritis	D010003	EFO_0002506	M15-M19	—	—	4	—	—	4
Constipation	D003248	HP_0002019	K59.0	—	1	3	—	—	4
Eye diseases	D005128	EFO_0003966	H44	1	1	1	—	1	3
Knee osteoarthritis	D020370	EFO_0004616	M17	—	—	3	—	—	3
Disease	D004194	EFO_0000408	R69	—	—	1	—	2	3
Fever	D005334	HP_0001945	R50.9	—	—	1	—	1	2
Hypoglycemia	D007003	HP_0001943	E16.2	1	—	1	—	—	2

Show 32 more

Indications Phases 2

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Central serous chorioretinopathy	D056833	—	H35.71	1	1	—	—	5	6
Myelodysplastic syndromes	D009190	—	D46	2	4	—	—	—	4
Stroke	D020521	EFO_0000712	I63.9	—	3	—	—	1	4
Renal cell carcinoma	D002292	EFO_0000376	—	—	3	—	—	—	3
Triple negative breast neoplasms	D064726	—	—	1	1	—	—	1	3
Ischemic stroke	D000083242	—	—	—	3	—	—	—	3
Recurrence	D012008	—	—	2	1	—	—	—	3
Preleukemia	D011289	—	—	2	2	—	—	—	2
Myelomonocytic leukemia chronic	D015477	—	C93.1	1	2	—	—	—	2
Kidney neoplasms	D007680	EFO_0003865	C64	—	2	—	—	—	2

Show 55 more

Indications Phases 1

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Malnutrition	D044342	EFO_0008572	E40-E46	4	—	—	—	4	8
Infections	D007239	EFO_0000544	—	2	—	—	—	2	4
Social psychology	D011593	—	—	3	—	—	—	—	3
Beta-thalassemia	D017086	Orphanet_848	D56.1	1	—	—	—	1	2
Fistula	D005402	—	—	1	—	—	—	1	2
Fasting	D005215	EFO_0002756	—	2	—	—	—	—	2
Pharmacokinetics	D010599	—	—	1	—	—	—	—	1
Small cell lung carcinoma	D055752	—	—	1	—	—	—	—	1
Congenital hyperinsulinism	D044903	—	—	1	—	—	—	—	1
Nesidioblastosis	D046768	EFO_0007318	E16.9	1	—	—	—	—	1

Show 15 more

Indications Without Phase

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Embryo transfer	D004624	—	—	—	—	—	—	3	3
Uveitis	D014605	HP_0000554	H20.9	—	—	—	—	2	2
Obstetric labor complications	D007744	—	—	—	—	—	—	2	2
Therapeutic equivalency	D013810	—	—	—	—	—	—	2	2
Angioid streaks	D000793	EFO_1000805	—	—	—	—	—	1	1
Myopia	D009216	EFO_0003927	H52.1	—	—	—	—	1	1
White dot syndromes	D000080363	—	H30.14	—	—	—	—	1	1
Multifocal choroiditis	D000080364	—	—	—	—	—	—	1	1
Hereditary eye diseases	D015785	—	—	—	—	—	—	1	1
Histoplasmosis	D006660	EFO_0007310	B39	—	—	—	—	1	1

Show 52 more

Epidemiology

Epidemiological information for investigational and approved indications

View more details

Drug

General

Drug common name	Lactitol
INN	lactitol
Description	Lactitol is a glycosyl alditol consisting of beta-D-galactopyranose and D-glucitol joined by a 1->4 glycosidic bond. It is used as a laxative, as an excipient, and as replacement bulk sweetener in some low-calorie foods. It has a role as a laxative, an excipient and a cathartic.
Classification	Small molecule
Drug class	—
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)	OC[C@H](O)[C@@H](O)[C@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)CO